Article Text

PDF
Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections
  1. A M Tammewar,
  2. L Cheng,
  3. O R Kayikcioglu,
  4. I A Falkenstein,
  5. I Kozak,
  6. M H Goldbaum,
  7. W R Freeman
  1. 1
    Joan and Irwin Jacobs Retina Center at the Shiley Eye Center, UCSD Department of Ophthalmology, La Jolla, California, USA
  1. Professor W R Freeman, Joan and Irwin Jacobs Retina Center, Shiley Eye Center, UCSD Department of Ophthalmology, La Jolla, CA 92037, USA; freeman{at}eyecenter.ucsd.edu

Abstract

Aims: To compare the non-decanted (standard) 4 mg versus the decanted 20 mg intravitreal triamcinolone acetonide (IVTA) injections and to assess their effect on intraocular pressure (IOP).

Methods: We retrospectively reviewed the records of 92 consecutive eyes, which received an intravitreal injection of either dose of triamcinolone acetonide, at a single retina centre. The change in IOP (elevation of at least 5 mm Hg from baseline or above 21 mm Hg) was analysed with a multivariate logistic analysis. The mean follow-up period in both groups was 27 weeks. A subgroup analysis comparing vitrectomised to non-vitrectomised eyes in both groups was also performed.

Results: Of the 92 eyes, 46% (23 of 51) in the 4 mg group versus 30% (12 of 41) in the 20 mg group had an IOP >21 mm of Hg (p = 0.14) after a mean follow-up period of 27 weeks. The vitrectomised eyes (3 of 24) in the 20 mg group had a significantly lower rate of IVTA induced IOP elevation than the non-vitrectomised eyes (9 of 17) (p = 0.013). The IOP elevation occurred significantly earlier in the 4 mg group (vitrectomised eyes 27 (SD 43) days and non-vitrectomised eyes 61 (52) days) than in the 20 mg group (vitrectomised eyes 104 (56) days and non-vitrectomised eyes 119 (82) days), independent of the vitreous status (vitrectomised p = 0.05 and non-vitrectomised p = 0.04). The mean value of initial high IOP in the non-vitrectomised eyes was higher in the 4 mg group than in the corresponding 20 mg group (p = 0.048).

Conclusion: Decanted 20 mg IVTA may not pose a significantly greater risk of IOP elevation than the 4 mg non-decanted IVTA.

Statistics from Altmetric.com

Footnotes

  • Funding: This research was supported in part by unrestricted retina research funds from Jacobs Retina Center, La Jolla, CA (WRF and LC). AMT has received a travel grant from Rameshwardasji Birla Smarak Kosh, Medical Research Center, Bombay Hospital Avenue, Mumbai, India.

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.